BC
Brainstorm Cell Therapeutics Inc
🇺🇸XNAS.BCLIUnited StatesHealthcare
$0.97USDdown -0.11 (-10.19%)Pre-marketDelayed1:27 PM
Price$0.97-0.11 (-10.19%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US10501E2019
- CUSIP
- 10501E102
Company
- Employees
- 19
- Headquarters
- New York, United States
- CEO
- Mr. Chaim Lebovits
Market
- Shares outstanding
- 11M
- Market cap
- $10.7M
Highlights
- Market cap
- $10.7M
- EPS LTM
- -$0.95
- P/E LTM
- -1.05
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $881K+3.77%up year on year
- Net income
- -$10.52M+8.09%up year on year
- Gross margin
- 85.13%+5.51%up year on year
- Free cash flow
- -$4.06M+57.2%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.